1. Home
  2. HFWA vs EVO Comparison

HFWA vs EVO Comparison

Compare HFWA & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heritage Financial Corporation

HFWA

Heritage Financial Corporation

HOLD

Current Price

$29.80

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$1.96

Market Cap

778.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HFWA
EVO
Founded
1927
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
778.3M
IPO Year
1997
2007

Fundamental Metrics

Financial Performance
Metric
HFWA
EVO
Price
$29.80
$1.96
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$30.50
$7.00
AVG Volume (30 Days)
441.7K
47.3K
Earning Date
04-23-2026
04-08-2026
Dividend Yield
3.53%
N/A
EPS Growth
58.06
N/A
EPS
0.90
N/A
Revenue
N/A
N/A
Revenue This Year
$45.85
$1.37
Revenue Next Year
$7.83
$10.05
P/E Ratio
$33.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.32
$1.90
52 Week High
$31.25
$4.27

Technical Indicators

Market Signals
Indicator
HFWA
EVO
Relative Strength Index (RSI) 50.84 38.88
Support Level $28.91 $1.90
Resistance Level $30.58 $3.84
Average True Range (ATR) 0.54 0.05
MACD -0.07 0.04
Stochastic Oscillator 41.89 21.31

Price Performance

Historical Comparison
HFWA
EVO

About HFWA Heritage Financial Corporation

Heritage Financial Corp is a bank holding company. The company, through its subsidiary, provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as non-interest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: